Lonchampt; Marie-Odile

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lonchampt; Marie-Odile.The latest application filed is for "product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer".

Company Profile

0.3.5

Lonchampt; Marie-Odile - Chevilly-Larue FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Product Comprising A Transduction Inhibitor Of Heterotrimeric G Protein Signals Combined With Another Anti-cancer Agent For Therapeutic Use In The Treatment Of Cancer App 20090270341 - PREVOST; Gregoire ; et al.	2009-10-29
Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment Grant 7,034,024 - Prevost , et al. April 25, 2	2006-04-25
Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein Grant 7,034,025 - Prevost , et al. April 25, 2	2006-04-25
Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer App 20060074078 - Prevost; Gregoire ; et al.	2006-04-06
Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein App 20060035899 - Prevost; Gregoire ; et al.	2006-02-16
Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors App 20040048849 - Prevost, Gregoire ; et al.	2004-03-11
Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein App 20030162786 - Prevost, Gregoire ; et al.	2003-08-28
Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein Grant 6,544,995 - Prevost , et al. April 8, 2	2003-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.